The human plasma proteome holds the promise of a revolution in disease diagnosis and
therapeutic monitoring provided that major challenges in proteomics and related disciplines …

We have merged four different views of the human plasma proteome, based on different
methodologies, into a single nonredundant list of 1175 distinct gene products. The …

… At the last Siena meeting, N. Leigh Anderson, in collaboration with Jeff Seilhamer, presented
the first multi-gene comparison plot of mRNA vs. protein abundances for cellular gene …

An analysis of all US Food and Drug Administration (FDA) approvals for protein-based
assays through 2008 reveals 109 unique protein targets in plasma or serum, as well as 62 …

Since 1990, the National Cancer Institute (NCI) has screened more than 60,000 compounds
against a panel of 60 human cancer cell lines. The 50-percent growth-inhibitory …

Verification of candidate biomarkers relies upon specific, quantitative assays optimized for
selective detection of target proteins, and is increasingly viewed as a critical step in the …

A method (denoted SISCAPA) for quantitation of peptides in complex digests is described. In
the method, anti-peptide antibodies immobilized on 100 nanoliter nanoaffinity columns are …

Mass spectrometry-based multiple reaction monitoring (MRM) quantitation of proteins can
dramatically impact the discovery and quantitation of biomarkers via rapid, targeted, …

Plasma, the soluble component of the human blood, is believed to harbor thousands of distinct
proteins, which originate from a variety of cells and tissues through either active secretion …

We have compiled from literature and other sources a list of 1261 proteins believed to be
differentially expressed in human cancer. These proteins, only some of which have been …